Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FOLIC ACID HEALTH CLAIMS SPECIFIC TO DIETARY SUPPLEMENTS ALLOWED

This article was originally published in The Tan Sheet

Executive Summary

FOLIC ACID HEALTH CLAIMS SPECIFIC TO DIETARY SUPPLEMENTS ALLOWED under a finalized proposed rule slated to appear in the Federal Register the week of Jan. 3. The notice finalizes FDA's Oct. 14 proposed rule that tentatively authorized a rotate health claim in the labeling of supplements and foods recommended for use by women of child-bearing age for the prevention of neural tube defects (NTDs) in newborns. FDA emphasized, however, that the soon-to-be published rule "is deemed to be a final regulation only with respect to dietary supplements."
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS082304

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel